Mitomycin C cross-resistance induced by adriamycin in human ovarian cancer cells in vitro. 1990

K Mizuno, and Y Furuhashi, and O Maeda, and M Iwata, and T Misawa, and M Kawai, and T Kano, and Y Tomoda
Department of Obstetrics and Gynecology, Nagoya University School of Medicine, Japan.

We prepared Adriamycin-resistant cancer cells by exposing an ovarian serous cystadenocarcinoma cell line to the drug. The resistant cells also showed cross-resistance to a wide variety of other compounds, including vincristine, vinblastine, actinomycin D, daunorubicin, mitomycin C and carboquone. Against vincristine, the cells showed a greater than 5,000-fold increase in resistance, far surpassing their resistance to the selection drug. The resistant cells displayed a decrease in intracellular Adriamycin content and an increase in the mRNA of the mdr-1 gene coding for P-glycoprotein, with no amplification of the DNA. In revertant cells, resistance to Adriamycin was lost, but that to mitomycin C was maintained. Adriamycin resistance was partially overcome by the addition of verapamil or cyclosporin A, but cross-resistance to mitomycin C was not influenced at all. These results strongly suggest that the resistance to mitomycin C observed in our Adriamycin-resistant cells was due to some other mechanism than that causing multidrug resistance.

UI MeSH Term Description Entries
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D003536 Cystadenocarcinoma A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed) Cystadenocarcinomas
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females

Related Publications

K Mizuno, and Y Furuhashi, and O Maeda, and M Iwata, and T Misawa, and M Kawai, and T Kano, and Y Tomoda
January 1991, Anticancer research,
K Mizuno, and Y Furuhashi, and O Maeda, and M Iwata, and T Misawa, and M Kawai, and T Kano, and Y Tomoda
January 1995, Anticancer research,
K Mizuno, and Y Furuhashi, and O Maeda, and M Iwata, and T Misawa, and M Kawai, and T Kano, and Y Tomoda
June 1984, Science (New York, N.Y.),
K Mizuno, and Y Furuhashi, and O Maeda, and M Iwata, and T Misawa, and M Kawai, and T Kano, and Y Tomoda
May 2012, The American journal of the medical sciences,
K Mizuno, and Y Furuhashi, and O Maeda, and M Iwata, and T Misawa, and M Kawai, and T Kano, and Y Tomoda
January 1991, Cancer chemotherapy and pharmacology,
K Mizuno, and Y Furuhashi, and O Maeda, and M Iwata, and T Misawa, and M Kawai, and T Kano, and Y Tomoda
June 1996, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
K Mizuno, and Y Furuhashi, and O Maeda, and M Iwata, and T Misawa, and M Kawai, and T Kano, and Y Tomoda
August 2001, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
K Mizuno, and Y Furuhashi, and O Maeda, and M Iwata, and T Misawa, and M Kawai, and T Kano, and Y Tomoda
January 1991, Bulletin du cancer,
K Mizuno, and Y Furuhashi, and O Maeda, and M Iwata, and T Misawa, and M Kawai, and T Kano, and Y Tomoda
July 1996, Biochemical pharmacology,
K Mizuno, and Y Furuhashi, and O Maeda, and M Iwata, and T Misawa, and M Kawai, and T Kano, and Y Tomoda
October 1983, American journal of clinical oncology,
Copied contents to your clipboard!